Navigation Links
FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS)
Date:3/11/2010

WOODCLIFF LAKE, N.J., March 11 /PRNewswire-FirstCall/ -- Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells.

The new outpatient dosing option provides physicians and patients with the flexibility of a dosing regimen with a reduced infusion time. Dacogen is the only hypomethylating agent approved for a five-day dosing regimen. The new regimen will be administered at a dose of 20 mg/m2 continuous intravenous (IV) infusion over one hour repeated daily for five days per cycle.  The cycle is repeated every four weeks.

The previously approved Dacogen three-day regimen is administered in an in-patient setting at a dose of 15 mg/m2 continuous IV infusion over three hours repeated every eight hours for three days per cycle and repeated every six weeks.

Three open-label, single-arm, multicenter studies were conducted to evaluate the safety and efficacy of Dacogen in MDS patients with any of the French-American-British (FAB) subtypes. In one study, 99 patients with International Prognostic Scoring System (IPSS) Intermediat
'/>"/>

SOURCE Eisai Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. European Union Approves Corn Stack with Herculex RW and Roundup Ready 2 Traits for Food, Feed, Import and Processing
2. EU Committee Approves New Food Applications for Marteks lifesDHA(TM)
3. EU Committee Approves New Food Applications for Martek's life'sDHA™
4. Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler
5. FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD
6. FDA Approves Boston Scientifics Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
7. Arpida Annual General Meeting of Shareholders Approves All Board Proposals
8. Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
9. FDA Approves Label Change for Non-Invasive Fibroid Treatment
10. FDA Approves SyntheMeds REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
11. FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... The Stirling Ultracold Model SU780U ultra-low ... USA, won the Outstanding New Product Award presented on ... and Environmental Repositories (ISBER) at their annual meeting in ... recognizes the company’s development and introduction of the world’s ... was presented to Global Cooling’s CEO Neill Lane by ...
(Date:5/16/2013)... May 16, 2013 Cambridge Healthtech Institute ... August 19-23, 2013 at the Renaissance Waterfront Hotel in ... provide a close-up look at the current strategies and ... bottom-line quality. Leaders in the field will reveal ... produce biopharmaceuticals with greater specificity and efficiency. , “In ...
(Date:5/16/2013)... As the weather warms, women everywhere are waiting for the ... make a statement with fashion, many change their makeup to ... mixes makeup and sweat to produce, and increase acne breakouts. ... warmer months, Adult Acne treatment , Probiotic Action shares ... to deter breakouts. , Recently, an article from ...
(Date:5/16/2013)... 2013 DNA Genotek, a leading provider of ... a sponsorship program in conjunction with the African Society of ... access and reduce the cost of DNA collection ... Human Heredity and Health in Africa (H3 Africa) Initiative and ... aim of the AfSHG is to build the ...
Breaking Biology Technology:Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3
... Presbyterian Cancer Center - Dallas,a joint venture between ... installed an Elekta Infinity system, enabling the facility ... (VMAT).,Elekta Infinity is the facility,s first image guided ... patients shortened treatment times with,the highest degree of ...
... Dax Denman Join as Company Enters Commercialization Phase, ... developers of,DIRECT TO ETHANOL(TM), the most advanced third ... the company with the,appointments Greg Schlicht as Senior ... Dax Denman as Senior Program Manager., Mr. ...
... Biotech Ltd. (Amex:,SVA), a leading provider of vaccines ... in Ukraine for its inactivated hepatitis A,vaccine, Healive, ... by,Biolik Biopharmaceutical Company, a vaccine manufacturer located in,Kharkov, ... Biolik will,also market and distribute Healive in Ukraine, ...
Cached Biology Technology:Presbyterian Cancer Center to Offer Cancer Patients High-End VMAT Treatments With the Installation of Elekta Infinity 2Presbyterian Cancer Center to Offer Cancer Patients High-End VMAT Treatments With the Installation of Elekta Infinity 3Algenol Biofuels Further Strengthens Team With Key Appointments 2Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine 2Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine 3
(Date:5/17/2013)... Jersey, and City University of New York have invented ... effectively clears organisms to be viewed under microscopes. Visikol ... is one of the few high-quality clearing solutions currently ... Enforcement Administration (DEA) due to its use as a ... for viewing organisms under a microscope. Without them, microscope ...
(Date:5/17/2013)... 2013, Shenzhen, China---- Why Tibetan antelope can live ... In a collaborative research published in Nature ... other institutes provide evidence that some genetic factors ... harsh highland environments. The data in this work ... mechanisms and the biology of other ruminant species. ...
(Date:5/17/2013)... Bethesda, MD The Federation of American Societies for ... of National Institutes of Health (NIH) funding trends highlighting ... to support critical research. The FASEB analysis follows a ... Francis Collins, MD, PhD, who testified that the $1.6 ... to sequestration is "having a substantial impact on the ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... this innovative solar power technology introduces a new paradigm ... in the world-wide effort to reduce greenhouse gases, it ... source of electricity. Yet several obstacles have been undermining ... actors are looking for a new approach towards the ...
... you want to improve the way you eat, the best way ... visualize yourself carrying it out, according to McGill researchers. ... we,ve known that for a while," says Brbel Knuper of McGill,s ... concrete plan about what they are going to do, they are ...
... method can effectively identify a sub-group of never-smoking lung ... increased risk of disease progression or recurrence, US researchers ... Clinic, Rochester, USA, and colleagues, reported the findings at ... February 2011, Lugano, Switzerland. Approximately 8% - ...
Cached Biology News:Floating solar panels 2Floating solar panels 3Quick, easy test identifies aggressive type of lung cancer in never-smokers 2Quick, easy test identifies aggressive type of lung cancer in never-smokers 3